Chair(s)

Introduction

During this session selected abstracts from the following topics will be presented in a 7,5-minute presentation:

• Drug delivery and manufacturing
• New medicines
• New generation of pharmaceutical scientists

Link to selected abstracts to follow

(SIG) Drug delivery and manufacturing

• RFMO-04-01 - Does swallowing tablets with an extremely thick (IDDSI Level 4) medication lubricant alter drug absorption? A randomised, single-dose crossover study in healthy adults
• RFMO-04-02 - Artificial Intelligence in Pharmaceutical Sciences: Fad or Future?
• RFMO-04-03 - Optimizing a tissue-targeted nucleic acid therapeutic (DNA, mRNA, siRNA, CRISPR/Cas9) delivery platform with unique cell uptake properties for in vivo applications, and use in hard-to-transfect cells
• RFMO-04-04 - Saturated fatty acids modulate the expression of breast cancer resistance protein (BCRP) at the blood-brain barrier.
• RFMO-04-05 - An artificial intelligence decision system for solubilization strategies of small molecule drug candidates: lessons from approved drugs by partially supervised learning
• RFMO-04-06 - Inorganic nanoparticles for overcoming biological barriers for advanced drug delivery
• RFMO-04-07 - Enhanced hyperthermia therapy by magneto-photothermal dual-mode treatments in MWCNTs/Mn0.5Zn0.5Fe2O4 nanohybrids
• RFMO-04-08 - Machine Learning Algorithms for Predicting Solubility of Small-Molecule Compounds in Organic Solvents

(SIG) New generation of pharmaceutical scientists

• RFMO-04-12 - A Deep Learning AI-Based System for Drug Identification

(SIG) New medicines

• RFMO-04-09 - Antimicrobial action and reversal of resistance in MRSA by difluorobenzamide derivatives targeted at FtsZ
• RFMO-04-10 - Investigation for Neuroprotective activity of Iris kashmiriana for treatment of dementia of Alzheimer’s type
• RFMO-04-11 - CYP4Z1: a potential target for breast cancer treatment by killing cancer stem cells